6-31270541-G-A
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_002117.6(HLA-C):c.620-56C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0015 ( 0 hom., cov: 2)
Exomes 𝑓: 0.0018 ( 135 hom. )
Failed GnomAD Quality Control
Consequence
HLA-C
NM_002117.6 intron
NM_002117.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.25
Publications
27 publications found
Genes affected
HLA-C (HGNC:4933): (major histocompatibility complex, class I, C) HLA-C belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. About 6000 HLA-C alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002117.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HLA-C | NM_002117.6 | MANE Select | c.620-56C>T | intron | N/A | NP_002108.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| HLA-C | ENST00000376228.10 | TSL:6 MANE Select | c.620-56C>T | intron | N/A | ENSP00000365402.5 | |||
| HLA-C | ENST00000383329.7 | TSL:6 | c.620-56C>T | intron | N/A | ENSP00000372819.3 | |||
| HLA-C | ENST00000415537.1 | TSL:6 | c.617-56C>T | intron | N/A | ENSP00000400410.1 |
Frequencies
GnomAD3 genomes AF: 0.00151 AC: 83AN: 54806Hom.: 0 Cov.: 2 show subpopulations
GnomAD3 genomes
AF:
AC:
83
AN:
54806
Hom.:
Cov.:
2
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00175 AC: 1218AN: 694688Hom.: 135 Cov.: 10 AF XY: 0.00223 AC XY: 766AN XY: 342974 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1218
AN:
694688
Hom.:
Cov.:
10
AF XY:
AC XY:
766
AN XY:
342974
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
63
AN:
11372
American (AMR)
AF:
AC:
63
AN:
17026
Ashkenazi Jewish (ASJ)
AF:
AC:
26
AN:
5942
East Asian (EAS)
AF:
AC:
27
AN:
10976
South Asian (SAS)
AF:
AC:
328
AN:
32836
European-Finnish (FIN)
AF:
AC:
106
AN:
25278
Middle Eastern (MID)
AF:
AC:
11
AN:
1842
European-Non Finnish (NFE)
AF:
AC:
537
AN:
561866
Other (OTH)
AF:
AC:
57
AN:
27550
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.342
Heterozygous variant carriers
0
72
144
216
288
360
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00151 AC: 83AN: 54846Hom.: 0 Cov.: 2 AF XY: 0.00177 AC XY: 46AN XY: 26044 show subpopulations ⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome
AF:
AC:
83
AN:
54846
Hom.:
Cov.:
2
AF XY:
AC XY:
46
AN XY:
26044
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
AC:
26
AN:
10684
American (AMR)
AF:
AC:
13
AN:
4856
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
724
East Asian (EAS)
AF:
AC:
1
AN:
1358
South Asian (SAS)
AF:
AC:
3
AN:
1496
European-Finnish (FIN)
AF:
AC:
3
AN:
3996
Middle Eastern (MID)
AF:
AC:
0
AN:
94
European-Non Finnish (NFE)
AF:
AC:
33
AN:
30560
Other (OTH)
AF:
AC:
1
AN:
650
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.241
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
2637
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.